logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
C

Curtis A. Lachowiez

Oregon Health and Science University
H指数:18
被引数:1,508

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Rapid clonal selection within early hematopoietic cell compartments presages outcome to ivosidenib combination therapy

早期造血细胞群内的快速克隆选择预示ivosidenib联合治疗的结局

Blood
IF23.1
2025-11-070
PRE
Sven Turkalj; Felix A. Radtke; Bilyana Stoilova; Rabea Mecklenbrauck; Angus J. Groom; Niels Asger Jakobsen; Curtis A. Lachowiez; Marlen Metzner; Batchimeg Usukhbayar; Mirian Angulo Salazar; Zhihong Zeng; Sanam Loghavi; Jennifer Marvin-Peek; Verena Körber; Farhad Ravandi; Ghayas Issa; Tapan Kadia; Vasiliki Symeonidou; Anne P. de Groot; Hagop Kantarjian; Koichi Takahashi; Marina Konopleva; Courtney D. DiNardo; Paresh Vyas
PTPN11 Mutations Are Associated with Shorter Survival in Patients with Acute Myeloid Leukemia Treated with Hypomethylating Agents and Venetoclax

PTPN11基因突变与接受表观遗传药物（包括低甲基化剂和Venetoclax）治疗的急性髓系白血病患者生存期缩短相关。

BLOOD
IF23.1
2024-11-050
PRE
Ravikumar, Vishvaas, I; Leonard, Jessica T.; Newell, Laura F.; Gandhi, Arpita; Meyers, Gabrielle; Hayes-Lattin, Brandon; Maziarz, Richard T.; Cook, Rachel J.; Traer, Elie; Swords, Ronan T.; Saultz, Jennifer N.; Tyner, Jeffrey W.; Heiblig, Mael; Zeidner, Joshua F.; Pollyea, Daniel A.; Lachowiez, Curtis A.
Impact of Social Determinants of Health on Access to Blood and Marrow Transplantation for Acute Myeloid Leukemia

社会决定因素对急性髓系白血病患者获得造血干细胞移植的影响

BLOOD
IF23.1
2024-11-050
PRE
Khare, Somya; Cook, Rachel J.; Desai, Amrita; Gandhi, Arpita; Goslee, Kelli; Hayes-Lattin, Brandon; Lachowiez, Curtis A.; Leonard, Jessica T.; Maziarz, Richard T.; Meyers, Gabrielle; Newell, Laura F.; Saultz, Jennifer N.; Swords, Ronan T.; Traer, Elie; Nemece, Eneida R.
Immunophenotypic Markers CD7 and CD56 Improve Risk Stratification of Frontline Hypomethylating Agents plus Venetoclax in Newly Diagnosed AML

免疫表型标志物CD7和CD56可改善一线低甲基化药物联合Venetoclax在初诊AML中的风险分层

BLOOD
IF23.1
2024-11-050
PRE
Lachowiez, Curtis A.; Peters, Daniel; Fang, Jacob; Kaempf, Andy; Leonard, Jessica T.; Newell, Laura F.; Gandhi, Arpita; Meyers, Gabrielle; Hayes-Lattin, Brandon; Maziarz, Richard T.; Cook, Rachel J.; Traer, Elie; Swords, Ronan T.; Tyner, Jeffrey W.; Zeidner, Joshua F.; Pollyea, Daniel A.; Saultz, Jennifer N.
Phase 1 Trial Testing the Novel Combination Therapy of Entrectinib and ASTX727 in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia Patients

I期临床试验：评估Entrectinib与ASTX727新型联合疗法在TP53突变复发/难治性急性髓系白血病患者中的疗效

BLOOD
IF23.1
2024-11-050
PRE
Tognon, Cristina; Mishra, Shikha; Kaempf, Andy; Park, Byung; Joshi, Sunil K.; Huang, Ariane; Kurtz, Stephen E.; Sax, Luca; Eide, Christopher A.; Johnson, Kara; Mahoney, Rachel; Lue, Michael James; Tong, Nicole; Guiducci, Lisa; Willians, Tara Lundberg; Solanki, Emma Indira; Cook, Rachel J.; Leonard, Jessica T.; Lachowiez, Curtis A.; Meyers, Gabrielle; Saultz, Jennifer N.; Traer, Elie; Tyner, Jeffrey W.; Borate, Uma; Swords, Ronan T.
NCAM1 (CD56) As a Predictor of Response to Standard Intensive Induction in Newly Diagnosed Acute Myeloid Leukemia

NCAM1 (CD56) 作为新诊断急性髓系白血病对标准强化诱导治疗的应答预测指标

BLOOD
IF23.1
2024-11-050
PRE
Saultz, Jennifer N.; Rai, Manoj; Kaempf, Andy; Bastola, Sanjog; Cho, Hyun; Long, Nicola; Lachowiez, Curtis A.; Meyers, Gabrielle; Leonard, Jessica T.; Gandhi, Arpita; Newell, Laura F.; Hayes-Lattin, Brandon; Maziarz, Richard T.; Cook, Rachel J.; Traer, Elie; Swords, Ronan T.; Tyner, Jeffrey W.
Outcomes By Frailty in IC-Ineligible Newly Diagnosed AML- a Real-World Evidence Comparison By Treatment with Hypomethylating Agents plus Ivosidenib or Venetoclax

按虚弱程度划分的IC不适用新诊断AML患者的结局——一项通过表观遗传药物联合伊沃西尼布或维奈克拉治疗的真实世界证据比较

BLOOD
IF23.1
2024-11-050
PRE
Smith, Douglas; Lachowiez, Curtis A.; Ambinder, Alexander J.; Binder, Gary; Angiolillo, Anne; Potluri, Ravi; Papademetriou, Eros; Leblanc, Thomas W.
Response patterns and impact of MRD in patients with IDH1/2-mutated AML treated with venetoclax and hypomethylating agents
BLOOD CANCER JOURNAL
IF11.6
2023-09-215
OAAI
Hammond, Danielle; Loghavi, Sanam; Wang, Sa A.; Konopleva, Marina Y.; Kadia, Tapan M.; Daver, Naval G.; Ohanian, Maro; Issa, Ghayas C.; Alvarado, Yesid; Short, Nicholas J.; Sasaki, Koji; Pemmaraju, Naveen; Montalban-Bravo, Guillermo; Lachowiez, Curtis A.; Maiti, Abhishek; Garcia-Manero, Guillermo; Jabbour, Elias J.; Borthakur, Gautam; Ravandi, Farhad; Takahashi, Koichi; Pierce, Sherry R.; Kantarjian, Hagop M.; Dinardo, Courtney D.
Clinical Correlates of Venetoclax-Based Combination Sensitivities to Augment Acute Myeloid Leukemia Therapy
BLOOD CANCER DISCOVERY
IF11.5
2023-09-118
PRE
Eide, Christopher A.; Kurtz, Stephen E.; Kaempf, Andy; Long, Nicola; Joshi, Sunil Kumar; Nechiporuk, Tamilla; Huang, Ariane; Dibb, Charles A.; Taylor, Akosha; Bottomly, Daniel; Mcweeney, Shannon K.; Minnier, Jessica; Lachowiez, Curtis A.; Saultz, Jennifer N.; Swords, Ronan T.; Agarwal, Anupriya; Chang, Bill H.; Druker, Brian J.; Tyner, Jeffrey W.
Targeted therapy with the mutant IDH2 inhibitor enasidenib for high-risk IDH2-mutant myelodysplastic syndrome
BLOOD ADVANCES
IF7.1
2023-05-2630
OAAI
DiNardo, Courtney D.; Venugopal, Sangeetha; Lachowiez, Curtis; Takahashi, Koichi; Loghavi, Sanam; Montalban-Bravo, Guillermo; Wang, Xuemei; Carraway, Hetty; Sekeres, Mikkael; Sukkur, Ameenah; Hammond, Danielle; Chien, Kelly; Maiti, Abhishek; Masarova, Lucia; Sasaki, Koji; Alvarado, Yesid; Kadia, Tapan; Short, Nicholas J.; Daver, Naval; Borthakur, Gautam; Ravandi, Farhad; Kantarjian, Hagop M.; Patel, Bhumika; Dezern, Amy; Roboz, Gail; Garcia-Manero, Guillermo
A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in IDH1-Mutated Myeloid Malignancies
BLOOD CANCER DISCOVERY
IF11.5
2023-04-2651
OA
Lachowiez, Curtis A.; Loghavi, Sanam; Zeng, Zhihong; Tanaka, Tomoyuki; Kim, Yi June; Uryu, Hidetaka; Turkalj, Sven; Jakobsen, Niels Asger; Luskin, Marlise R.; Duose, Dzifa Y.; Tidwell, Rebecca S. S.; Short, Nicholas J.; Borthakur, Gautam; Kadia, Tapan M.; Masarova, Lucia; Tippett, George D.; Bose, Prithviraj; Jabbour, Elias J.; Ravandi, Farhad; Daver, Naval G.; Garcia-Manero, Guillermo; Kantarjian, Hagop; Garcia, Jacqueline S.; Vyas, Paresh; Takahashi, Koichi; Konopleva, Marina; DiNardo, Courtney D.
Contemporary outcomes in IDH-mutated acute myeloid leukemia: The impact of co-occurring NPM1 mutations and venetoclax-based treatment
AMERICAN JOURNAL OF HEMATOLOGY
IF9.9
2022-09-1517
PRE
Lachowiez, Curtis A.; Reville, Patrick K.; Kantarjian, Hagop; Jabbour, Elias; Borthakur, Gautam; Daver, Naval; Issa, Ghayas; Furudate, Ken; Tanaka, Tomoyuki; Pierce, Sherry; Tang, Guilin; Patel, Keyur P.; Medeiros, Jeffrey; Abbas, Hussein A.; Haddad, Fadi; Hammond, Daniel; Short, Nicholas J.; Maiti, Abhishek; Yilmaz, Musa; Sasaki, Koji; Takahashi, Koichi; Pemmaraju, Naveen; Konopleva, Marina; Garcia-Manero, Guillermo; Ravandi, Farhad; Kadia, Tapan M.; Loghavi, Sanam; DiNardo, Courtney D.

研究方向

暂未获取到该数据
C
Courtney D. DiNardo
H 指数:94论文数:1,588被引数:4.8万
S
Sanam Loghavi
H 指数:50论文数:645被引数:1.3万
K
Koichi Takahashi
H 指数:69论文数:840被引数:1.7万
N
Naval Daver
H 指数:89论文数:1,412被引数:3.3万
F
Farhad Ravandi
H 指数:126论文数:2,443被引数:6.8万
H
Hagop M. Kantarjian
H 指数:230论文数:5,484被引数:26.4万
T
Tapan M. Kadia
H 指数:89论文数:1,752被引数:3.2万
N
Nicholas J. Short
H 指数:64论文数:1,057被引数:1.7万
J
Jennifer N. Saultz
H 指数:15论文数:152被引数:1,671
R
Ronan Swords
H 指数:36论文数:296被引数:9,475